Could a low dose of ketamine ease anxiety in pancreatic cancer?
NCT ID NCT05086250
First seen Jun 24, 2026 · Last updated Aug 14, 2026 · Updated 3 times
Summary
This study tests whether a low dose of oral ketamine can safely help with anxiety in people with pancreatic cancer. Twenty participants will receive both ketamine and a placebo at different times to compare effects. The main goal is to see if such a study is even possible, not to prove the treatment works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ketamine
- What this could lead to
- If this works, it could point toward a new way to manage anxiety in people with pancreatic cancer.
- What could go wrong
- This is a very early, small study with only 20 people. It is designed mainly to see if the idea is feasible, not to prove ketamine works. Side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a VR headset calm nerves before surgery?
- Nature as therapy? a new trial tests outdoor outings for anxious kids
- Could a vaccine help fight Hard-to-Treat cancers?
- Can an AI chatbot calm nerves before a C-Section as well as a doctor?